Syncom Formul.

{
  "main_header": {
    "sid": 831770,
    "name": "Syncom Formul.",
    "stock_name": "Syncom Formul.",
    "full_name": "Syncom Formulations (India) Ltd",
    "name_url": "stocks-analysis/syncom-formul",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "22.20",
    "chg": 2.14,
    "chgp": "10.67%",
    "dir": 1,
    "prev_price": "20.06",
    "mcapval": "2,075.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524470,
    "symbol": "SYNCOMF",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE312C01025",
    "curr_date": "Sep 28, 04:01 PM",
    "curr_time": "17:07 PM",
    "last_traded_at": "Sep 28, 04:01 PM IST",
    "bse_nse_vol": "8.64 cr",
    "exc_status": "Active",
    "traded_date": "Sep 28, 2026",
    "traded_date_str": "2026 09 28",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/syncom-formul-831770-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Broad-Based Technical Strength Lifts Syncom Formulations (India) Ltd to 52-Week High of Rs 23.44",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syncom-formulations-india-ltd-hits-new-52-week-high-at-rs2344-4207236",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SyncomFormulati_priceRelatedfactors_4207236.png",
        "date": "2026-09-28 15:41:59",
        "description": "With a decisive surge to Rs 23.44 on 28 Sep 2026, Syncom Formulations (India) Ltd has reached a fresh 52-week high, marking a 130% rally from its low of Rs 10.21 over the past year. This milestone comes amid a backdrop of broad technical alignment and sustained price momentum, even as the broader Sensex index trades near its own 52-week lows."
      },
      {
        "title": "Syncom Formulations Surges on Exceptional Volume Amid Positive Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syncom-formulations-surges-on-exceptional-volume-amid-positive-momentum-4206656",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SyncomFormulati_most_active_equities_by_volume_4206656.png",
        "date": "2026-09-28 12:00:10",
        "description": "Syncom Formulations (India) Ltd witnessed a remarkable surge in trading volume and price on 28 Sep 2026, emerging as one of the most actively traded stocks in the Pharmaceuticals & Biotechnology sector. The micro-cap company’s shares rallied by over 9%, supported by robust volume and technical strength, signalling renewed investor interest and potential accumulation."
      },
      {
        "title": "Syncom Formulations (India) Ltd: Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syncom-formulations-india-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4202922",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SyncomFormulati_technicaldot_4202922.png",
        "date": "2026-09-24 08:03:10",
        "description": "Syncom Formulations (India) Ltd has experienced a nuanced shift in its technical momentum, transitioning from a bullish to a mildly bullish trend as of late September 2026. Despite a recent day decline of 1.81%, the stock’s technical indicators present a complex picture, with bullish signals from MACD and moving averages contrasting with bearish RSI readings and mixed monthly trends. This article analyses these technical parameters in detail, contextualising the stock’s performance against broader market benchmarks and its own historical returns."
      },
      {
        "title": "Syncom Formulations (India) Ltd Shows Bullish Momentum Amid Technical Upgrades",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syncom-formulations-india-ltd-shows-bullish-momentum-amid-technical-upgrades-4199106",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SyncomFormulati_technicaldot_4199106.png",
        "date": "2026-09-21 08:02:52",
        "description": "Syncom Formulations (India) Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical indicators and an upgrade in its MarketsMOJO rating from Sell to Hold. The pharmaceutical and biotechnology company’s shares have surged 6.49% in a single day, reflecting renewed investor confidence amid a broader positive technical trend."
      },
      {
        "title": "Syncom Formulations (India) Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/syncom-formulations-india-ltd-is-rated-hold-4198804",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SyncomFormulati_mojoScore_4198804.png",
        "date": "2026-09-20 10:10:05",
        "description": "Syncom Formulations (India) Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 24 August 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 20 September 2026, providing investors with the most recent and relevant data to assess the company’s prospects."
      },
      {
        "title": "Syncom Formulations (India) Ltd Technical Momentum Shifts Amid Mixed Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syncom-formulations-india-ltd-technical-momentum-shifts-amid-mixed-indicators-4194195",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SyncomFormulati_technicaldot_4194195.png",
        "date": "2026-09-16 08:07:09",
        "description": "Syncom Formulations (India) Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent downgrade in daily price performance, the stock’s longer-term technical indicators suggest cautious optimism for investors."
      },
      {
        "title": "Syncom Formulations (India) Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/syncom-formulations-india-ltd-is-rated-hold-4188047",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SyncomFormulati_mojoScore_4188047.png",
        "date": "2026-09-09 10:10:04",
        "description": "Syncom Formulations (India) Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 24 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 September 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Syncom Formulations Gains 5.65%: 5 Key Factors Driving the Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syncom-formulations-gains-565-5-key-factors-driving-the-weeks-momentum-4183644",
        "imagepath": "",
        "date": "2026-09-05 15:04:14",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>31 Aug:</strong> Technical rating upgraded to Hold, shares surge on bullish momentum</p>\n                    <p><strong>2 Sep:</strong> New 52-week high at Rs.20.89 amid sustained gains</p>\n                    <p><strong>3 Sep:</strong> Hits another 52-week high at Rs.22.18 with exceptional volume spike</p>\n                    <p><strong>3 Sep:</strong> Valuation shifts to very expensive, signalling heightened price attractiveness</p>\n                    <p><strong>4 Sep:</strong> Week closes at Rs.20.56, consolidating recent gains</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><..."
      },
      {
        "title": "Syncom Formulations Sees Exceptional Volume Surge Amidst Sustained Gains",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syncom-formulations-sees-exceptional-volume-surge-amidst-sustained-gains-4180782",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SyncomFormulati_most_active_equities_by_volume_4180782.png",
        "date": "2026-09-03 10:00:14",
        "description": "Syncom Formulations (India) Ltd has emerged as one of the most actively traded stocks by volume on 3 September 2026, registering a remarkable surge in investor participation and sustained price appreciation. The pharmaceutical company’s shares have demonstrated robust momentum, supported by a significant increase in traded volumes and a notable upgrade in its mojo grade, signalling a potential shift in market sentiment."
      }
    ],
    "total": 315,
    "sid": "831770",
    "stock_news_url": "https://www.marketsmojo.com/news/syncom-formulations-india-831770"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "24-Sep-2026",
      "details": "We would like to inform you that Pursuant to the provisions of SEBI (PIT) Regulation 2015. The window for dealing in the securities of the company shall remain closed from 1st Oct 2026 and shall remain closed until 48 hours after the declaration of Unaudited Standalone & Consolidated Financial Results of the company for the quarter and half year ended on 30th September 2026.",
      "source": "BSE"
    },
    {
      "caption": "Corporate Announcement/Information Under Regulation 42 Of SEBI (LODR) Regulations 2015 Regarding Record Date.",
      "datetime": "18-Sep-2026",
      "details": "We are pleased to inform you that pursuant to the provision of regulation 42 of SEBI (LODR) regulation 2015 and section 91 of companies Act 2013 the \"Record Date\" has been fixed as Wednesday 23rd September 2026 for the purpose of determining the entitlement of members for the payment of dividend.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "08-Sep-2026",
      "details": "Submission of copy of newpaper clippings of notice of 38th Annual General Meeting (AGM) Remote E-Voting Record Date and other details.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Syncom Formulations (India) Ltd has declared <strong>10%</strong> dividend, ex-date: 23 Sep 26",
          "dt": "2026-09-23",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Syncom Formulations (India) Ltd has announced <strong>1:10</strong> stock split, ex-date: 19 Aug 13",
          "dt": "2013-08-19",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Syncom Formulations (India) Ltd has announced <strong>5:2</strong> bonus issue, ex-date: 19 Aug 13",
          "dt": "2013-08-19",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Syncom Formulations (India) Ltd has announced <strong>1:2</strong> rights issue, ex-date: 13 May 09",
          "dt": "2009-05-13",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Broad-Based Technical Strength Lifts Syncom Formulations (India) Ltd to 52-Week High of Rs 23.44

2026-09-28 15:41:59

With a decisive surge to Rs 23.44 on 28 Sep 2026, Syncom Formulations (India) Ltd has reached a fresh 52-week high, marking a 130% rally from its low of Rs 10.21 over the past year. This milestone comes amid a backdrop of broad technical alignment and sustained price momentum, even as the broader Sensex index trades near its own 52-week lows.

Read full news article

Syncom Formulations Surges on Exceptional Volume Amid Positive Momentum

2026-09-28 12:00:10

Syncom Formulations (India) Ltd witnessed a remarkable surge in trading volume and price on 28 Sep 2026, emerging as one of the most actively traded stocks in the Pharmaceuticals & Biotechnology sector. The micro-cap company’s shares rallied by over 9%, supported by robust volume and technical strength, signalling renewed investor interest and potential accumulation.

Read full news article

Syncom Formulations (India) Ltd: Technical Momentum Shifts Amid Mixed Indicator Signals

2026-09-24 08:03:10

Syncom Formulations (India) Ltd has experienced a nuanced shift in its technical momentum, transitioning from a bullish to a mildly bullish trend as of late September 2026. Despite a recent day decline of 1.81%, the stock’s technical indicators present a complex picture, with bullish signals from MACD and moving averages contrasting with bearish RSI readings and mixed monthly trends. This article analyses these technical parameters in detail, contextualising the stock’s performance against broader market benchmarks and its own historical returns.

Read full news article

Syncom Formulations (India) Ltd Shows Bullish Momentum Amid Technical Upgrades

2026-09-21 08:02:52

Syncom Formulations (India) Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical indicators and an upgrade in its MarketsMOJO rating from Sell to Hold. The pharmaceutical and biotechnology company’s shares have surged 6.49% in a single day, reflecting renewed investor confidence amid a broader positive technical trend.

Read full news article

Syncom Formulations (India) Ltd is Rated Hold

2026-09-20 10:10:05

Syncom Formulations (India) Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 24 August 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 20 September 2026, providing investors with the most recent and relevant data to assess the company’s prospects.

Read full news article

Syncom Formulations (India) Ltd Technical Momentum Shifts Amid Mixed Indicators

2026-09-16 08:07:09

Syncom Formulations (India) Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent downgrade in daily price performance, the stock’s longer-term technical indicators suggest cautious optimism for investors.

Read full news article

Syncom Formulations (India) Ltd is Rated Hold

2026-09-09 10:10:04

Syncom Formulations (India) Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 24 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 September 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

Syncom Formulations Gains 5.65%: 5 Key Factors Driving the Week’s Momentum

2026-09-05 15:04:14

Key Events This Week

31 Aug: Technical rating upgraded to Hold, shares surge on bullish momentum

2 Sep: New 52-week high at Rs.20.89 amid sustained gains

3 Sep: Hits another 52-week high at Rs.22.18 with exceptional volume spike

3 Sep: Valuation shifts to very expensive, signalling heightened price attractiveness

4 Sep: Week closes at Rs.20.56, consolidating recent gains

Week Open

<...

Read full news article

Syncom Formulations Sees Exceptional Volume Surge Amidst Sustained Gains

2026-09-03 10:00:14

Syncom Formulations (India) Ltd has emerged as one of the most actively traded stocks by volume on 3 September 2026, registering a remarkable surge in investor participation and sustained price appreciation. The pharmaceutical company’s shares have demonstrated robust momentum, supported by a significant increase in traded volumes and a notable upgrade in its mojo grade, signalling a potential shift in market sentiment.

Read full news article

View All News